These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 19811386)

  • 1. Therapeutic strategies to optimize the efficacy of nicotine replacement therapies.
    Berlin I
    COPD; 2009 Aug; 6(4):272-6. PubMed ID: 19811386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotine replacement therapy for smoking cessation.
    Silagy C; Mant D; Fowler G; Lancaster T
    Cochrane Database Syst Rev; 2000; (3):CD000146. PubMed ID: 10908462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotine replacement therapy for smoking cessation.
    Silagy C; Lancaster T; Stead L; Mant D; Fowler G
    Cochrane Database Syst Rev; 2001; (3):CD000146. PubMed ID: 11686953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine replacement therapy for smoking cessation.
    Silagy C; Mant D; Fowler G; Lancaster T
    Cochrane Database Syst Rev; 2000; (2):CD000146. PubMed ID: 10796494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotine replacement therapy for smoking cessation.
    Stead LF; Perera R; Bullen C; Mant D; Lancaster T
    Cochrane Database Syst Rev; 2008 Jan; (1):CD000146. PubMed ID: 18253970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of prior nicotine replacement therapy on smoking cessation efficacy.
    Durcan MJ; White J; Jorenby DE; Fiore MC; Rennard SI; Leischow SJ; Nides MA; Ascher JA; Johnston JA
    Am J Health Behav; 2002; 26(3):213-20. PubMed ID: 12018757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
    Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
    J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders.
    Evins AE; Culhane MA; Alpert JE; Pava J; Liese BS; Farabaugh A; Fava M
    J Clin Psychopharmacol; 2008 Dec; 28(6):660-6. PubMed ID: 19011435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease.
    Wagena EJ; Knipschild PG; Huibers MJ; Wouters EF; van Schayck CP
    Arch Intern Med; 2005 Oct; 165(19):2286-92. PubMed ID: 16246996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smoking cessation interventions for smokers with current or past depression.
    van der Meer RM; Willemsen MC; Smit F; Cuijpers P
    Cochrane Database Syst Rev; 2013 Aug; (8):CD006102. PubMed ID: 23963776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nicotine addiction and current therapy of smoking cessation].
    Picciolo M; Gigante D; Nunziata A
    Clin Ter; 2005; 156(4):159-71. PubMed ID: 16342517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefits and risks of pharmacological smoking cessation therapies in chronic obstructive pulmonary disease.
    Wagena EJ; Zeegers MP; van Schayck CP; Wouters EF
    Drug Saf; 2003; 26(6):381-403. PubMed ID: 12688831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials.
    Lerman C; Jepson C; Wileyto EP; Epstein LH; Rukstalis M; Patterson F; Kaufmann V; Restine S; Hawk L; Niaura R; Berrettini W
    Neuropsychopharmacology; 2006 Jan; 31(1):231-42. PubMed ID: 16123753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial.
    Tulloch HE; Pipe AL; Els C; Clyde MJ; Reid RD
    BMC Med; 2016 Jun; 14():80. PubMed ID: 27233840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Smoking cessation: Pharmacological strategies different from standard treatments].
    Underner M; Perriot J; Peiffer G; Harika-Germaneau G; Jaafari N
    Rev Pneumol Clin; 2018 Sep; 74(4):205-214. PubMed ID: 29773262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interventions for smoking cessation and reduction in individuals with schizophrenia.
    Tsoi DT; Porwal M; Webster AC
    Cochrane Database Syst Rev; 2010 Jun; (6):CD007253. PubMed ID: 20556777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial of nicotine replacement therapy in combination with reduced-nicotine cigarettes for smoking cessation.
    Becker KM; Rose JE; Albino AP
    Nicotine Tob Res; 2008 Jul; 10(7):1139-48. PubMed ID: 18629723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes from an outpatient smoking-cessation clinic.
    Roth MT; Andrus MR; Westman EC
    Pharmacotherapy; 2005 Feb; 25(2):279-88. PubMed ID: 15767242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bupropion: a review of its use in the management of smoking cessation.
    Holm KJ; Spencer CM
    Drugs; 2000 Apr; 59(4):1007-24. PubMed ID: 10804045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.
    Rose JE; Behm FM; Drgon T; Johnson C; Uhl GR
    Mol Med; 2010; 16(7-8):247-53. PubMed ID: 20379614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.